MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.37M
P/E Ratio
N/A
Total Cash
150.33M
Projected Growth
N/A
Total Debt
6.64M
Revenue
53.48M
Risk (Beta)
-0.85
Dividend Yield
N/A
Total Cash/Share
22.86
Total Debt/Equity
N/A
Revenue/Share
9.25 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XLO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for XLO
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com